Search results

These forms of collaboration work with students in first- and second-cycle education. Our Director of Studies for first- and second-cycle education, Björn Olofsson, organises and coordinates many of these activities.Master's thesis / Degree projectHosting a master's thesis project (or degree project as it is formally called) is the most common form of collaboration between LTH and industry within

https://www.control.lth.se/collaboration-and-outreach/collaboration-in-education - 2026-09-09

Finnish engineer and expert in advanced control strategies and fault monitoring (b. 1952) Sirkka-Liisa Jämsä-Jounela is a Finnish engineer and a specialist in process automation. She has done comprehensive work in developing new and efficient process control and management theories, increasing the sustainability of production processes. Affiliation: Aalto UniversityBeing a prominent figure in the

https://www.control.lth.se/collaboration-and-outreach/female-influencers-automatic-control/historical-female-influencers-automatic-control/sirkka-liisa-jamsa-jounela - 2026-09-09

Italian professor of automatic control and expert in nonlinear and hybrid system control theory and the applications to traffic control, smart grids, and biological systems (b. 1953) Maria Domenica Di Benedetto is an Italian engineer and professor of automatic control. She is mainly known for her advances in the science of nonlinear and hybrid system control theory and its many applications to tra

https://www.control.lth.se/collaboration-and-outreach/female-influencers-automatic-control/historical-female-influencers-automatic-control/maria-domenica-di-benedetto - 2026-09-09

French control theorist and expert in uncertain nonlinear systems and hybrid systems (b. 1953) Françoise Lamnabhi-Lagarrigue, a distinguished French professor emeritus and CNRS research fellow, is best known for her theoretical advances in analyzing and controlling complex nonlinear systems and their application in power and neural networks. Affiliation: French National Centre for Scientific Resea

https://www.control.lth.se/collaboration-and-outreach/female-influencers-automatic-control/historical-female-influencers-automatic-control/francoise-lamnabhi-lagarrigue - 2026-09-09

British innovator of tools and approaches for a more sustainable operation of large-scale production plants (b. 1953) Nina Thornhill is a British physicist and control engineer. She is mainly known for her innovative approaches and tools for process monitoring and the detection and diagnosis of persistent faults in large-scale industrial systems, such as chemical plants. Affiliation: University Co

https://www.control.lth.se/collaboration-and-outreach/female-influencers-automatic-control/historical-female-influencers-automatic-control/nina-thornhill - 2026-09-09

If you arrive by airMalmö Airport (Sturup)Malmö Airport - about 30 km southeast of Lund - has frequent connections with Stockholm but only a few regular international flights. There is a bus service from the airport to LTH and to Lund central station, usually in connection with planes from Stockholm. Website of Buss Bogdan bus service.For Taxi service, see below.Copenhagen Airport (Kastrup)Copenha

https://www.control.lth.se/contact/travel-information - 2026-09-09

The links on this page open in Lund University's Research Portal. Var god vänta... The Department's profile in Lund University's Research Portal Staff, research output, projects, and infrastructure

https://www.control.lth.se/publications - 2026-09-09

 Please wait... Alumni Doctors and Licentiates Graduated from the department Working with us? Overview of available positions at our department.

https://www.control.lth.se/staff - 2026-09-09

Management Head of DepartmentKarl-Erik Årzénkarl-erik [dot] arzen [at] control [dot] lth [dot] se (karl-erik.arzen@control.lth.se)+46 46-2228782Deputy Head of DepartmentEmma Teglingemma [dot] tegling [at] control [dot] lth [dot] se (emma[dot]tegling[at]control[dot]lth[dot]se)+46 46-2228792 Directors of study First and second-cycle studiesBjörn Olofssonbjorn [dot] olofsson [at] control [dot] lth [d

https://www.control.lth.se/contact - 2026-09-09

24 November 2026 09:30 to 26 November 2026 15:00 | Event for children and young people Registration of interest is open 31 August at 13.00 until 2 October.. During week 48, the robotics labs at LTH and Cognitive Science at Lund University invite school classes to to guided tours of robotics!For school classes of a maximum of 30 participants, we offer 13 sessions of 90 minutes. First, we give a who

https://www.control.lth.se/calendar/robotics-week-school-classes-24-26-november - 2026-09-09

CREATE Health: Translational Cancer Center CREATE Health develops and translates cutting-edge diagnostic and therapeutic innovations into real-world clinical solutions that measurably improve patient outcomes and advance public health. We combine state-of-the-art technologies, including AI-driven data analytics, next-generation sequencing, advanced molecular imaging, precision biologics and target

https://www.createhealth.lth.se/start - 2026-09-09

Centre Management Sara EkCenter Directorsara [dot] ek [at] immun [dot] lth [dot] se (sara[dot]ek[at]immun[dot]lth[dot]se) Kristina LundbergDeputy Directorkristina [dot] lundberg [at] immun [dot] lth [dot] se (kristina[dot]lundberg[at]immun[dot]lth[dot]se) Corinna RichterResearch Coordinatorcorinna [dot] richter [at] immun [dot] lth [dot] se (corinna[dot]richter[at]immun[dot]lth[dot]se) Board Carl

https://www.createhealth.lth.se/about/organisation - 2026-09-09

Collaboration, commercialisation as well as high-impact publications allow to accelerate translation of breakthrough therapies and diagnostics into clinical practice. Principle Investigators within CREATE Health have founded several spin-off companies which are already helping patients all around the world.  Beside that, tens of research articles with ground-breaking discoveries have been publishe

https://www.createhealth.lth.se/impact - 2026-09-09

 Var god vänta...

https://www.createhealth.lth.se/impact/publications - 2026-09-09

Open positions will be advertised on Lund University's website and on our social media channels.If you are a student and interested in doing a Master's or ExJobb project, please contact the PI of the group of interest directly.

https://www.createhealth.lth.se/about/recruitment - 2026-09-09

Links will open on the respective websites.Region SkåneMedicon VillageCHUV in LausanneTMUCI in Tianjin, ChinaOslo Cancer ClusterWorking together is an integral part of CREATE Health’s DNA. We can proudly say that CREATE Health’s researchers are highly engaged in many different collaborations and networks – too many to name all of them here. For detailed information on our researchers’ collaborativ

https://www.createhealth.lth.se/about/partners - 2026-09-09

Lead BiologicsLead Biologics was founded in 2022 by Thoas Fioretos, Carl Sandén and Marcus Järås (Lund University), Kjell Sjöström (Innovagen) and Niklas Landberg (SUS). The company combines state-of-the-art technologies with unique patient cohorts to identify multiple novel therapeutic targets in leukemias and solid tumors. The aim is to develop a first-in-class treatment against SLAMF6. A majors

https://www.createhealth.lth.se/impact/spin-companies - 2026-09-09

The Translational Cancer Faster Forward doctoral/postdoctoral programmes (2018-2025). The CanFaster programme is supported by the European Union’s Marie Skłodowska-Curie COFUND programme (Horizon 2020 framework) based on the "Mobility across borders" philosophy. The CanFaster programme has attracted international PhD and Postdoc fellows (ER) with an interest in applied medical research in oncology

https://www.createhealth.lth.se/impact/canfaster - 2026-09-09

The links below open on the respective publication website.In vivo dendritic cell reprogramming for cancer immunotherapy.Authors: Ascic, E., Catena, X., et al.Publication: Science 386, 6719Year: 2024Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab.Authors: Meng, P., Dalal, H., Chen, Y., Brueffer, C., Gladchuk, S., Alcaide, M., ... &

https://www.createhealth.lth.se/impact/canfaster/canfaster-publications - 2026-09-09

Immunotherapy has transformed the cancer treatment landscape leading to long-term responses. However, these strategies are effective in a limited number of patients and often lose their efficacy as the tumor progresses. Insufficient antigen presentation mediated by MHC downregulation and exclusion of functional antigen-presenting cells (APCs) from the tumor microenvironment (TME) are critical evas

https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects/inducing-anti-tumor-immunity-situ-direct-reprograming-cancer-cells-cdc1s - 2026-09-09